Zdrowie i gospodarka · 31/12/1998

FDA Revises Financial Disclosure Requirements for Clinical Investigators

The Food and Drug Administration (FDA) is revising its financial disclosure requirements for clinical investigators to address concerns raised by the Pharmaceutical Research Manufacturers Association (PhRMA). The changes aim to reduce administrative burdens while ensuring the agency receives relevant information for reviewing marketing applications.